Atuação do farmacêutico na equipe de cuidado de pacientes em transplante renal: uma revisão integrativa
Introduction: the advances in clinical services performed by the pharmacist, allowed their participation in the individualized care of patients and have been growing significantly and having a positive impact on health promotion, prevention and recovery. Objective: to carry out a literature review o...
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | bachelorThesis |
Idioma: | pt_BR |
Publicado em: |
Universidade Federal do Rio Grande do Norte
|
Assuntos: | |
Endereço do item: | https://repositorio.ufrn.br/handle/123456789/48420 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Resumo: | Introduction: the advances in clinical services performed by the pharmacist, allowed their participation in the individualized care of patients and have been growing significantly and having a positive impact on health promotion, prevention and recovery. Objective: to carry out a literature review on the clinical intervention actions of the pharmacist in the care of kidney transplant patients. Methodology: integrative review carried out from January to March 2022 with studies published in the last 5 years in the main databases PubMed/MEDLINE, ScienceDirect, Scopus, EMBASE and Web of Science in the English language. The acronym PICO was used, which consists of: Population; Intervention; Comparison and Outcome. Results: the search in the databases resulted in a total of 4,358 published articles and only 10 were selected to compose the review, according to the eligibility criteria. Among the included studies, we observed predominantly male and non-elderly patients. Conclusion: It was possible to observe the actions of clinical intervention of the pharmacist in the care of kidney transplant patients in the 10 selected studies as well as the effective integration of this professional in the interprofessional teams of kidney transplantation. Different types of pharmaceutical interventions were carried out: educational campaigns capable of reducing the use of opioids; increase in patients' knowledge about medication use; there was reestablishment of therapeutic levels in 70% of patients due to improved adherence to pharmacotherapy; reduction of discrepancies through medication reconciliation; reduction in the use of prophylactic antibiotic therapy; there was a 50% reduction in hospitalization rates and also in hospital and medication costs; control of glycemic levels reduced almost 90% of hospitalizations for post-transplant hyperglycemia. |
---|